Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSEMBLY BIOSCIENCES, INC. Director's Dealing 2022

May 27, 2022

33081_dirs_2022-05-27_d9fea2df-8fed-42c1-9594-fb4f6d0e0bc5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2022-05-25

Reporting Person: Johnson-Pratt Lisa (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-05-25 Stock Option (right to buy) $1.69 A 20000 Acquired 2032-05-25 Common Stock (20000) Direct

Footnotes

F1: Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 25, 2023 and (2) the date of the Issuer's 2023 annual meeting of stockholders.